Acerca de Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. was a pharmaceutical company headquartered in South San Francisco, California that developed and marketed cancer treatment medications. It was founded and incorporated with the California Secretary of State in February 1992 by venture capitalist Kevin J. Kinsella and Frank McCormick, Ph.D., FRS, D.Sc. (Hon.), a renowned British-American biochemist. McCormick served as the chief scientific officer until 1996, while Kinsella chaired the company's board of directors. On March 26, 1996, Onyx withdrew its corporate registration with the California Secretary of State and reincorporated in the state of Delaware in advance of successfully taking the company public on the NASDAQ exchange using National Market symbol ONXX on May 9, 1996. In 2009, the company acquired private biotechnology company Proteolix for US$276 million in cash plus additional milestone payments. In January 2012, the company was named "the top biotechnology takeover target in 2012" in an industry survey conducted by the ISI Group. Onyx president and CEO N. Anthony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, by the end of August 2013, Amgen announced that it was acquiring Onyx in an agreed US$10.4 billion deal.
Source: Wikipedia
SedeCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Fundado2013
EstadoActivo
Patentes60 patentes
METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOREP4558143A4 · 2026
Methods of treating multiple myelomaUS12636340B2 · 2026
Inicie sesión para ver las 60 patentes
Consulte la cartera completa de patentes, con números de publicación, fechas y familias.
Iniciar sesión Crear una cuenta con su correo electrónicoEs gratis
Al continuar, acepta el Acuerdo de usuario, la Política de privacidad y la Política de cookies de Heelky.
Reseñas
Aún no hay reseñas. ¿Has trabajado con Onyx Pharmaceuticals, Inc.? Sé el primero en compartir tu experiencia.
Información legal
| Razón social | Onyx Pharmaceuticals, Inc. |
|---|---|
| LEI | 549300K47GO90N8J4853Ver en GLEIF ↗ |
| Domicilio social | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| Estado | Activo |
Fuentes: GLEIF · actualizado 16 de Octubre de 2026
Contacto y enlaces
Ubicación
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
¿Es tu empresa?
Reclama esta página gratis para añadir tu logo, productos, fotos y empleos, y para responder a las reseñas.
Reclamar esta páginaÚnase a Heelky para conectar, contratar y crecer
Cree una cuenta gratuita para enviar mensajes, postularse a empleos y publicar misiones.
Únase ahora: es gratis